Real-world evidence and nonrandomized data in health technology assessment: use existing methods to address unmeasured confounding?

被引：12
作者：
Sammon, Cormac J. [1 ]
Leahy, Thomas P. [1 ]
Gsteiger, Sandro [2 ]
Ramagopalan, Sreeram [2 ]
机构：
[1] PHMR LTD, London, England
[2] F Hoffmann La Roche Ltd, Basel, Switzerland
来源：
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH | 2020年 / 9卷 / 14期
关键词：
confounding; HTA; real-world evidence; SENSITIVITY-ANALYSIS;
D O I：
10.2217/cer-2020-0112
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：969 / 972
页数：4
相关论文
共 22 条
  • [1] [Anonymous], 2018, USE REAL WORLD EVIDE
  • [2] Australian Department of Health, 2016, GUID PREP SUBM PHARM
  • [3] How unmeasured confounding in a competing risks setting can affect treatment effect estimates in observational studies
    Barrowman, Michael Andrew
    Peek, Niels
    Lambie, Mark
    Martin, Glen Philip
    Sperrin, Matthew
    [J]. BMC MEDICAL RESEARCH METHODOLOGY, 2019, 19 (1)
  • [4] Comparative effectiveness from a single-arm trial and real-world data: alectinib versus ceritinib
    Davies, Jessica
    Martinec, Michael
    Delmar, Paul
    Coudert, Mathieu
    Bordogna, Walter
    Golding, Sophie
    Martina, Reynaldo
    Crane, Gracy
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2018, 7 (09) : 855 - 865
  • [5] Eichinger B, 2016, GESUNDH QUAL, V21, P279
  • [6] Faria R, 2015, 17 NICE DEC SUPP UN, V17
  • [7] French National Authority for Health, 2020, INN MED ASS ACT PLAN
  • [8] Real-world evidence for coverage decisions: opportunities and challenges
    Hampson, Grace
    Towse, Adrian
    Dreitlein, William B.
    Henshall, Chris
    Pearson, Steven D.
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2018, 7 (12) : 1133 - 1143
  • [9] Health Information and Quality Authority, 2019, GUID EV CLIN EFF HLT
  • [10] Institute for Clinical and Economic Review, 2020, 2020 2023 VAL ASS FR
123